Park Place Capital’s Halozyme HALO Stock Holding History

Park Place Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.8K	Sell	600 -20	-3%	-$1.41K	0.01%	388
2025 Q4	$41.7K	Hold	620	–	–	0.01%	351
2025 Q3	$45.5K	Sell	620 -466	-43%	-$31K	0.01%	344
2025 Q2	$57.5K	Hold	1,086	–	–	0.01%	329
2025 Q1	$69.3K	Buy	1,086 +182	+20%	+$10.6K	0.02%	303
2024 Q4	$43.2K	Sell	904 -451	-33%	-$23.1K	0.01%	374
2024 Q3	$77.6K	Buy	1,355 +1,209	+828%	+$69.3K	0.02%	318
2024 Q2	$7.64K	Hold	146	–	–	﹤0.01%	650
2024 Q1	$5.94K	Hold	146	–	–	﹤0.01%	719
2023 Q4	$5.4K	Hold	146	–	–	﹤0.01%	714
2023 Q3	$5.58K	Hold	146	–	–	﹤0.01%	840
2023 Q2	$5.27K	Hold	146	–	–	﹤0.01%	862
2023 Q1	$5.58K	Hold	146	–	–	﹤0.01%	853
2022 Q4	$8K	Buy	+146	New	+$7.47K	﹤0.01%	792

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Park Place Capital's HALO Position: Q1 2026 in Review

Park Place Capital reduced its Halozyme (HALO) stake by 3.2% in Q1 2026, selling an estimated $1.41K and leaving 600 shares worth $38.8K. The position accounts for 0.01% of the portfolio, ranked #388.

Park Place Capital first reported a position in HALO in Q4 2022 and has held it in 14 quarters since. The position peaked at $77.6K in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Park Place Capital held 600 shares of Halozyme worth $38.8K as of Q1 2026.
Park Place Capital sold 20 Halozyme shares in Q1 2026, an estimated $1.41K.
Halozyme made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #388 holding.
Park Place Capital first reported a position in Halozyme in Q4 2022 and has held it in 14 quarters since.
Park Place Capital's Halozyme position peaked at $77.6K in Q3 2024.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.